Targeting of C‐type lectin‐like receptor 2 or P2Y12 for the prevention of platelet activation by immunotherapeutic CpG oligodeoxynucleotides: comment
U. Flierl; T. L. Nero; B. Lim; R. K. Andrews; M. W. Parker; E. E. Gardiner; K. Peter
Author Information: Baker Heart and Diabetes Institute
|Checking for direct PDF access through Ovid|
Abstract unavailable for this article.